Monday 19 November 2018
Home      All news      Contact us      English
reuters - 3 month ago

Long-acting injection a shot in the arm for GSK s HIV business

A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker s key HIV business.

Related news

Latest News
Hashtags:   

acting

 | 

injection

 | 

business

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources